Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01351467 · ClinicalTrials.gov registry record

Web-based Genetic Research on Parkinson's Disease

A clinical trial of Parkinson's Disease, sponsored by 23andMe.

Completed
Registry status
13,576
Enrollment target
1
Study location

NCT01351467: Completed study of Parkinson's Disease, sponsored by 23andMe.

NCT01351467 is a study of Parkinson's Disease that has completed, run by 23andMe. The registered enrollment target is 13,576 participants, above the 549-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (2373% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01351467, a study of Parkinson's Disease, has completed, sponsored by 23andMe.

COMPLETED
Registry status
13,576 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine how genes and environment affect risk for Parkinson's disease.

Primary Outcome

We want to learn how genes and environment could play role in Parkinson's disease risk and progression

Conditions Studied

Study Locations (1)

California

  • Www.23Andme.Com/Pd - Mountain View

Trial Details

FieldValue
Enrollment Target 13,576 participants
Start Date 2009-04
Est. Completion 2021-06-23
23andMe

6 total trials

What the finished NCT01351467 record still lists

NCT01351467 is an observational study that tracks outcomes without assigning an intervention. Its 13,576 participants enrollment target places it among the larger protocols in the corpus, above the 549-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (2373% higher).

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 0 interventions.

NCT01351467 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01351467 about?

NCT01351467 is a clinical study titled "Web-based Genetic Research on Parkinson's Disease". The purpose of this study is to examine how genes and environment affect risk for Parkinson's disease.

What is the current status of trial NCT01351467?

This trial is currently completed. The enrollment target is 13,576 participants. The study started on 2009-04. Estimated completion is 2021-06-23.

What conditions does trial NCT01351467 study?

This clinical trial studies the following conditions: Parkinson's Disease.

Who is sponsoring clinical trial NCT01351467?

This trial is sponsored by 23andMe, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01351467 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01351467's enrollment target sits among peer trials

13,576 3rd of 158 higher than 156 of 158 other Parkinson's Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05141396 · 13,400 participants · NA

    Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)

  • NCT06058767 · 13,764 participants · NA

    Preschool Hearing Screening

  • NCT05991453 · 13,000 participants · NA

    Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

  • NCT07177352 · 13,000 participants · Phase 3

    Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01351467, the US trial registry maintained by the National Library of Medicine. NCT01351467 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.